top of page

Mwandishi:

Mhariri:

Imeboershwa:

ULY CLINIC

ULY CLINIC

17 Februari 2026, 14:31:27

Anaphylaxis
Anaphylaxis

Anaphylaxis

Anaphylaxis is an acute, rapidly progressive, life-threatening systemic hypersensitivity reaction caused by sudden massive release of mediators from mast cells and basophils.

It commonly begins with:

  • Scalp itching

  • Diffuse erythema

  • Urticaria

  • Angioedema

This may rapidly progress to:

  • Bronchospasm

  • Laryngeal edema

  • Hypotension (shock)

  • Gastrointestinal hyperperistalsis

  • Cardiac arrhythmias


Common causes

  • Antibiotics (especially penicillins)

  • Other medications (NSAIDs, anesthetics)

  • Radiographic contrast media

  • Hymenoptera stings (bees, wasps)

  • Foods — especially crustaceans, nuts, eggs, milk


Pathophysiology

Usually IgE-mediated (Type I hypersensitivity):

Allergen exposure → IgE cross-linking → mast cell degranulation → release of:

  • Histamine

  • Leukotrienes

  • Prostaglandins

  • Cytokines

Effects:

  • Vasodilation → hypotension

  • Increased capillary permeability → edema

  • Bronchoconstriction → respiratory distress

  • Mucus secretion


Signs & Symptoms


Skin (most common)

  • Urticaria (hives)

  • Angioedema (lips, eyelids, tongue)

  • Flushing

  • Generalized itching


Respiratory

  • Shortness of breath

  • Wheezing

  • Stridor

  • Hoarseness

  • Laryngeal edema


Cardiovascular

  • Hypotension

  • Tachycardia

  • Dizziness

  • Syncope

  • Shock


Gastrointestinal

  • Abdominal cramps

  • Vomiting

  • Diarrhea


Neurologic

  • Anxiety

  • Confusion

  • Collapse


Diagnostic Criteria

Clinical diagnosis — do not delay treatment for tests

Anaphylaxis is highly likely if any ONE of the following occurs rapidly after exposure to allergen:


1. Skin involvement PLUS respiratory compromise or hypotension

OR


2. Two or more of:

  • Skin/mucosal symptoms

  • Respiratory compromise

  • Reduced blood pressure

  • Persistent gastrointestinal symptoms

OR


3. Hypotension after exposure to known allergen


Investigations

(After stabilization only)

  • Serum tryptase (within 1–3 hrs)

  • Full blood count

  • Renal and electrolytes

  • Arterial oxygen saturation

  • ECG if severe reaction

  • Allergy testing later (skin prick/IgE)


Treatment — MEDICAL EMERGENCY


Immediate First Aid (Non-Pharmacological)

  • Stop exposure to trigger

  • Call emergency help

  • Lay patient supine and elevate legs

  • Give high-flow oxygen

  • Secure airway

  • Establish IV access


Pharmacological Treatment


First-line (Life-saving)

Adrenaline (Epinephrine) IM — immediately

  • Adults: 0.5 mg (0.5 mL of 1:1000) IM lateral thigh

  • Children: 0.01 mg/kg IM (max 0.5 mg)

  • Repeat every 5–15 minutes if needed


Fluids

  • Rapid IV normal saline bolus (shock)


Adjunct Medications (AFTER adrenaline)**

Antihistamines:

  • Chlorpheniramine 4–16 mg POOR

  • Promethazine 25–50 mg POOR

  • Cetirizine 10 mg PO dailyOR

  • Loratadine 10 mg PO daily

⚠ Warn patient about drowsiness


Corticosteroids

  • Hydrocortisone IV (prevents biphasic reaction)


Bronchospasm

  • Salbutamol nebulization

Refractory Shock

  • IV adrenaline infusion (ICU care)


Observation

  • Monitor at least 6–24 hours (risk of biphasic reaction)


Prevention

  • Identify and avoid triggers (penicillin, foods, stings)

  • Medical alert bracelet

  • Prescribe adrenaline auto-injector if recurrent risk

  • Educate patient and family

  • Refer for allergy testing

  • Exclude drug reactions or infections in recurrent acute episodes


Complications

  • Airway obstruction

  • Cardiac arrest

  • Hypoxic brain injury

  • Death


Prognosis

  • Excellent with rapid adrenaline administration

  • Delayed treatment increases mortality


References

  • Tanzania Ministry of Health. Standard Treatment Guidelines & National Essential Medicines List (STG/NEMLIT). 7th ed. Dodoma: MoH; 2023.

  • World Allergy Organization. Anaphylaxis guidelines 2020 update. J Allergy Clin Immunol Pract. 2020.

  • Resuscitation Council UK. Emergency treatment of anaphylactic reactions. 2021.

  • Simons FER, Ardusso LRF, Bilò MB, et al. International consensus on anaphylaxis. Allergy. 2020.

  • World Health Organization. WHO Model Formulary 2023. Geneva: WHO; 2023.


Imeandikwa;

3 Novemba 2020, 12:24:20

bottom of page